Search research articles
Contact Us
Filters
Showing results (361-370 of 390) with videos related to
Page
of 39
Sort By:
Biomaterials
|
January 14, 2016
Cell source determines the immunological impact of biomimetic nanoparticles
Michael Evangelopoulos, Alessandro Parodi, Jonathan O Martinez, et al.
Advanced Functional Materials
|
July 14, 2015
Hierarchically-Structured Magnetic Nanoconstructs with Enhanced Relaxivity and Cooperative Tumor Accumulation
Ayrat Gizzatov, Jaehong Key, Santosh Aryal, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 27, 2014
Colocalized delivery of rapamycin and paclitaxel to tumors enhances synergistic targeting of the PI3K/Akt/mTOR pathway
Elvin Blanco, Takafumi Sangai, Suhong Wu, et al.
Theranostics
|
January 2, 2018
A Novel DNA Aptamer for Dual Targeting of Polymorphonuclear Myeloid-derived Suppressor Cells and Tumor Cells
Haoran Liu, Junhua Mai, Jianliang Shen, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
September 21, 2011
Gadolinium metallofullerenol nanoparticles inhibit cancer metastasis through matrix metalloproteinase inhibition: imprisoning instead of poisoning cancer cells
Huan Meng, Gengmei Xing, Elvin Blanco, et al.
Nature Biotechnology
|
March 15, 2016
An injectable nanoparticle generator enhances delivery of cancer therapeutics
Rong Xu, Guodong Zhang, Junhua Mai, et al.
Plos Computational Biology
|
June 11, 2016
Theory and Experimental Validation of a Spatio-temporal Model of Chemotherapy Transport to Enhance Tumor Cell Kill
Zhihui Wang, Romica Kerketta, Yao-Li Chuang, et al.
Cell Reports
|
May 5, 2015
Porous silicon microparticle potentiates anti-tumor immunity by enhancing cross-presentation and inducing type I interferon response
Xiaojun Xia, Junhua Mai, Rong Xu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
October 8, 2013
Leveraging nanochannels for universal, zero-order drug delivery in vivo
Silvia Ferrati, Daniel Fine, Junping You, et al.
Ebiomedicine
|
January 19, 2019
PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis
Cristian Rodriguez-Aguayo, Emine Bayraktar, Cristina Ivan, et al.
Page
of 39
Search research articles
Search
Showing results (361-370 of 390) with videos related to
Sort By:
Page
of 39
Biomaterials
|
January 14, 2016
Cell source determines the immunological impact of biomimetic nanoparticles
Michael Evangelopoulos, Alessandro Parodi, Jonathan O Martinez, et al.
Advanced Functional Materials
|
July 14, 2015
Hierarchically-Structured Magnetic Nanoconstructs with Enhanced Relaxivity and Cooperative Tumor Accumulation
Ayrat Gizzatov, Jaehong Key, Santosh Aryal, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 27, 2014
Colocalized delivery of rapamycin and paclitaxel to tumors enhances synergistic targeting of the PI3K/Akt/mTOR pathway
Elvin Blanco, Takafumi Sangai, Suhong Wu, et al.
Theranostics
|
January 2, 2018
A Novel DNA Aptamer for Dual Targeting of Polymorphonuclear Myeloid-derived Suppressor Cells and Tumor Cells
Haoran Liu, Junhua Mai, Jianliang Shen, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
September 21, 2011
Gadolinium metallofullerenol nanoparticles inhibit cancer metastasis through matrix metalloproteinase inhibition: imprisoning instead of poisoning cancer cells
Huan Meng, Gengmei Xing, Elvin Blanco, et al.
Nature Biotechnology
|
March 15, 2016
An injectable nanoparticle generator enhances delivery of cancer therapeutics
Rong Xu, Guodong Zhang, Junhua Mai, et al.
Plos Computational Biology
|
June 11, 2016
Theory and Experimental Validation of a Spatio-temporal Model of Chemotherapy Transport to Enhance Tumor Cell Kill
Zhihui Wang, Romica Kerketta, Yao-Li Chuang, et al.
Cell Reports
|
May 5, 2015
Porous silicon microparticle potentiates anti-tumor immunity by enhancing cross-presentation and inducing type I interferon response
Xiaojun Xia, Junhua Mai, Rong Xu, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
October 8, 2013
Leveraging nanochannels for universal, zero-order drug delivery in vivo
Silvia Ferrati, Daniel Fine, Junping You, et al.
Ebiomedicine
|
January 19, 2019
PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis
Cristian Rodriguez-Aguayo, Emine Bayraktar, Cristina Ivan, et al.
Page
of 39